These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
544 related items for PubMed ID: 28295828
1. Are the ACOSOG Z0011 Trial Findings Being Applied to Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy? Kantor O, Pesce C, Liederbach E, Wang CH, Winchester DJ, Yao K. Breast J; 2017 Sep; 23(5):554-562. PubMed ID: 28295828 [Abstract] [Full Text] [Related]
4. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer. Yao K, Liederbach E, Pesce C, Wang CH, Winchester DJ. J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731 [Abstract] [Full Text] [Related]
5. Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes. Bonneau C, Hequet D, Estevez JP, Pouget N, Rouzier R. Eur J Surg Oncol; 2015 Aug; 41(8):998-1004. PubMed ID: 25986854 [Abstract] [Full Text] [Related]
6. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era. Mann JM, Wu X, Christos P, Nagar H. Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423 [Abstract] [Full Text] [Related]
11. Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event. Barrio AV, Montagna G, Mamtani A, Sevilimedu V, Edelweiss M, Capko D, Cody HS, El-Tamer M, Gemignani ML, Heerdt A, Kirstein L, Moo TA, Pilewskie M, Plitas G, Sacchini V, Sclafani L, Tadros A, Van Zee KJ, Morrow M. JAMA Oncol; 2021 Dec 01; 7(12):1851-1855. PubMed ID: 34617979 [Abstract] [Full Text] [Related]
13. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. Reitsamer R, Peintinger F, Rettenbacher L, Prokop E. J Surg Oncol; 2003 Oct 01; 84(2):63-7. PubMed ID: 14502778 [Abstract] [Full Text] [Related]
14. Neoadjuvant chemotherapy and timing of sentinel lymph node biopsy in different molecular subtypes of breast cancer with clinically negative axilla. Bi Z, Liu J, Chen P, Liu Y, Zhao T, Wang C, Zhang Z, Sun X, Qiu P, Cong B, Song X, Wang Y. Breast Cancer; 2019 May 01; 26(3):373-377. PubMed ID: 30666563 [Abstract] [Full Text] [Related]
16. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T, Mucke J, Markwardt J, Schlag PM, Bembenek A. J Surg Oncol; 2006 Feb 01; 93(2):109-19. PubMed ID: 16425290 [Abstract] [Full Text] [Related]
17. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance for Clinical Trials in Oncology. JAMA; 2013 Oct 09; 310(14):1455-61. PubMed ID: 24101169 [Abstract] [Full Text] [Related]
18. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery. Kozak MM, Horst KC, Gutkin PM, Jacobson CE, Walck E, von Eyben R, Dirbas FM. Clin Breast Cancer; 2020 Oct 09; 20(5):431-438. PubMed ID: 32522481 [Abstract] [Full Text] [Related]